Armistice Capital’s Calidi Biotherapeutics CLDI Stock Holding History

Armistice Capital’s Portfolio CLDI Stock Details CLDI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$210K	Buy	+879,000	New	+$660K	0.01%	225
2025 Q3	–	Sell	-66,000	Closed	-$182K	–	347
2025 Q2	$182K	Sell	66,000 -210,833	-76%	-$1.02M	0.01%	183
2025 Q1	$1.88M	Buy	+276,833	New	+$3.16M	0.05%	150

Other funds holding CLDI

Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return

Warberg Asset Management Winnetka, Illinois $343M AUM 23.37% 1-Year Est. Return

HighTower Advisors

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RS Crum Inc Newport Beach, California $517M AUM 16.68% 1-Year Est. Return

Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return

Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Belpointe Asset Management Reno, Nevada $2.74B AUM 20.71% 1-Year Est. Return